Skip to main content

Cancers of the Male and Female Reproductive Systems

  • Chapter
PET/CT in Clinical Practice

Abstract

In contrast to many other tumor groups, the role of FDG-PET and PET/CT in gynecological and testicular malignancies is much less clearly defined. There is, however, reliable evidence that FDG-PET does have a useful role in the management of these cancers and, with the introduction of PET/CT, this is likely to advance. FDG-PET experience in gynecological malignancies has, to date, been largely confined to ovarian and cervical carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Chapter 8

  • Belhocine T, Thille A, Fridman V, et al. Contribution of whole-body 18FDG PET imaging in the management of cervical cancer. Gynecol Oncol 2002;87:90–97.

    Article  PubMed  Google Scholar 

  • Belhocine TZ. 18F-FDG PET imaging in posttherapy monitoring of cervical cancers: from diagnosis to prognosis. J Nucl Med 2004;45:1602–1604.

    PubMed  Google Scholar 

  • Berchuk A, Boente MP, Bast RC Jnr. The use of tumour markers in the management of patients with gynaecological carcinomas. Clin Obstet Gynecol 1992;35:45–54.

    Article  Google Scholar 

  • Fenchel S, Grab D, Nuessle K, et al. Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. Radiology 2002;223:780–788.

    Article  PubMed  Google Scholar 

  • Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, Sixth Edition. New York: Springer, 2002.

    Google Scholar 

  • Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001;19:3745–3749.

    PubMed  CAS  Google Scholar 

  • Grigsby PW, Siegel BA, Dehdashti F, Mutch DG. Posttherapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys 2003;55:907–913.

    Article  PubMed  Google Scholar 

  • Hain SF, O’Doherty MJ, Timothy AR, et al. Fluorodeoxyglucose-PET in the evaluation of germ cell tumours at relapse. Br J Cancer 2000;83:863–869.

    Article  PubMed  CAS  Google Scholar 

  • Hain SF, O’Doherty MJ, Timothy AR et al. Fluorodeoxyglucose-PET in the initial staging of germ cell tumours. Eur J Nucl Med 2000;27:590–594.

    Article  PubMed  CAS  Google Scholar 

  • Havrilesky LJ, Kulasingam SL, Matchar DB, Myere ER. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 2005 (1):183–191.

    Article  Google Scholar 

  • Hubner KF, McDonald TW, Niethammer JG, Smith GT, Gould HR, Buonocore E. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG). Gynecol Oncol 1993;51:197–204.

    Article  PubMed  CAS  Google Scholar 

  • Lai CH, Huang KG, See LC et al. Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography. Cancer Feb 1, 2004;100(3):544–552.

    Article  PubMed  Google Scholar 

  • Lassen U, Daugaard G, Eigtved A et al. Whole body FDG-PET in patients with stage I non-seminomatous germ cell tumours. Eur J Nucl Med Mol Imaging 2005;30:396–402.

    Article  Google Scholar 

  • Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre-and post-menopausal patients: assessment by PET/CT. J Nucl Med 2004;45:266–271.

    PubMed  Google Scholar 

  • Lin WC, Hung YC, Yeh LS, Kao CH, Yen RF, Shen YY. Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol 2003;89:73–76.

    Article  PubMed  Google Scholar 

  • Ma SY, See LC, Lai CH, et al. Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients. J Nucl Med 2003;44:1775–1783.

    PubMed  Google Scholar 

  • Miller TR, Pinkus E, Dehdashti F, Grigsby PW. Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer. J Nucl Med 2003;44:192–197.

    PubMed  Google Scholar 

  • Narayan K, Hicks RJ, Jobling T, Bernshaw D, McKenzie AF. A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer 2001;11:263–271.

    Article  PubMed  CAS  Google Scholar 

  • Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, et. al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001;218:776–782.

    PubMed  CAS  Google Scholar 

  • Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001;218(3):776–782.

    PubMed  CAS  Google Scholar 

  • Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, et al. Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. Radiology 2001;218(3):776–782.

    PubMed  CAS  Google Scholar 

  • Rose PG, Adler LP, Rodriguez M, Faulhaber PF, Abdul-Karim FW, Miraldi F. Positron emission tomography for evaluating paraaortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 1999;17:41–45.

    PubMed  CAS  Google Scholar 

  • Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med 2003;44:347–352.

    PubMed  Google Scholar 

  • Tempany CM, Zou KH, Silverman SG, et al. Staging of advanced ovarian cancer: comparison of imaging modalities-report from the Radiological Diagnostic Oncology Group. Radiology 2000;215:761–767.

    PubMed  CAS  Google Scholar 

  • Tsai CS, Chang TC, Lai CH, et al. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. Int J Radiat Oncol Biol Phys 2004;58: 1506–1512.

    Article  PubMed  Google Scholar 

  • Unger JB, Ivy JJ, Connor P, et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. Gynecol Oncol 2004;94(1):212–216.

    Article  PubMed  Google Scholar 

  • Unger JB, Ivy JJ, Connor P, et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. Gynecol Oncol 2004;94(1):212–216.

    Article  PubMed  Google Scholar 

  • Yen TC, See LC, Chang TC, et al. Defining the priority of using 18F-FDG PET for recurrent cervical cancer. J Nucl Med 2004;45:1632–1639.

    PubMed  Google Scholar 

  • Yoshida Y, Kurokawa T, Kawahara K, et al. Metabolic monitoring of advanced uterine cervical cancer neoadjuvant chemotherapy by using [F-18]-fluorodeoxyglucose positron emission tomography: preliminary results in three patients. Gynecol Oncol 2004;95:597–602.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag London Limited

About this chapter

Cite this chapter

Wilson, L. (2007). Cancers of the Male and Female Reproductive Systems. In: PET/CT in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-84628-504-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-504-2_8

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-430-4

  • Online ISBN: 978-1-84628-504-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics